Page 181 - ESHRE2019

15:00 O-300
Soluble urokinase plasminogen activator receptor (suPAR) in plasma as a biomarker of early first trimester pregnancy viability and location compared with hCG, progesterone and estradiol
A. García-Alix Grynnerup1, J. Friis Petersen2, N.H. Mitchell3, K. Løssl4, S. Sørensen5, A. Lindhard6, L.J. Friis-Hansen7, A. Pinborg4, A. Nyboe Andersen4, E.C.L. Løkkegaard2
1Copenhagen University Hospital Hvidovre, Department of Obstetrics and Gynecology, Hvidovre Copenhagen, Denmark
2North Zealand Hospital- Copenhagen University Hospital, Department of Obstetrics and Gynecology, Copenhagen, Denmark
3Copenhagen University Hospital Hvidovre, Department of Clinical Biochemistry, Hvidovre Copenhagen, Denmark
4Rigshospitalet- Copenhagen University Hospital, Fertility Clinic, Copenhagen, Denmark
5Copenhagen University Hospital Hvidovre, Clinical research Center, Hvidovre Copenhagen, Denmark
6Zealand University Hospital Roskilde, Department of Obstetrics and Gynecology, Roskilde, Denmark
7North Zealand Hospital- Copenhagen University Hospital, Department of Clinical Biochemistry, Copenhagen, Denmark
Adverse/ reproductive outcomes of reduced pregnancy and live birth rates after In Vitro Fertilization in women with previous caesarean section: a retrospective cohort study
J. Vissers1, T. Sluckin1, C. Repelaer van Driel-Delprat1, R. Schats1, C. De Groot1, C. Lambalk1, J. Twisk2, J. Huirne1
1Amsterdam UMC- Vrije Universiteit Amsterdam, Obstetrics- Gynaecology and Reproductive Medicine, Amsterdam, The Netherlands
2Amsterdam UMC- Vrije Universiteit Amsterdam, Epidemiology and Biostatistics, Amsterdam, The Netherlands
15:15 O-301
SCIENTIFIC PROGRAMME, WEDNESDAY, 26 JUNE I VIENNA, AUSTRIA – 23 TO 26 JUNE 2019 181
SCIENTIFIC PROGRAMME WEDNESDAY, 26 JUNE